EZR and familial pancreatic carcinoma: Consistent with findings in osteosarcoma, Ezrin was found to be highly expressed in pancreatic cancer tissues and to positively regulate cell proliferation and invasion through the activation of the Akt/mTOR pathway (Meng et al., 2010; Quan et al., 2019; Chang et al., 2020).